BP000423-HEV-235: Recombinant HEV Mosaic
Source: E. coli-derived.
Purity > 95%, by 10% PAGE.
Applications: WB, ELISA.BP000423-HEV-236: Recombinant HEV ORF2 (452-617 a.a.)
Source: E. coli-derived.
Purity > 95%, by 10% PAGE.
Applications: WB, ELISA.BP000423-HEV-271: Recombinant HEV ORF2 (633-659 a.a.)
Source: E. coli-derived.
Purity > 95%, by 10% PAGE.
Applications: WB, ELISA.BP000423-HEV-272: Recombinant HEV ORF2 (403-461 a.a.)
Source: E. coli-derived.
Purity > 95%, by 10% PAGE.
Applications: WB, ELISA.BP000423-HEV-273: Recombinant HEV ORF3
Source: E. coli-derived.
Purity > 95%, by 10% PAGE.
Formulation: 20 mM Tris-HCl, pH-8, 10 mM B-ME and 8 M urea.
Applications: WB, ELISA.BP000423-HEV-274: Recombinant HEV Mosaic-S
Source: E. coli-derived.
Purity > 95%, by 10% PAGE.
Applications: WB, ELISA.BP000502-PRO-321: Human Urinary Trypsin Inhibitor-Ulinastatin (UTI) Protein
Source: Human Urine-derived.
Human UTI has an activity of 1000 IU/mg.
Purity: > 98% by RP-HPLC and SDS-PAGE.BP000502-PRO-608: Recombinant Human Urinary Trypsin Inhibitor-Ulinastatin (UTI) Protein
Source: Pichia Pastoris-derived.
Human UTI has an activity of greater than 3000 U/mg.
Purity: > 98% by RP-HPLC and anion-exchange FPLC.